Apr
8
2025
On demand

Conducting rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Conducting rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study

In this collaborative case study presentation, industry experts will discuss the latest innovations in rapid microbiological methods for environmental monitoring within the aseptic filling of cell and gene therapy drug products. Case studies highlighting the efficiency and the qualification of biofluorescent particle counters (BFPCs) in gloveless, robotic, aseptic filling isolators will be presented.

Attendees will learn the impact of new and ever-changing industry regulations surrounding aseptic filling, and best practices for adherence to regulations and adoption of new methods designed to ensure the highest drug product quality, safety, and efficiency. Learn how quality by design (QbD) principles can remove human interventions and indirect contact surfaces, minimize sources of particle generation, and more.

  • Learn about the best practices for adoption of BFPCs within robotic gloveless isolators and view a case study highlighting the key design elements of a BFPC
  • See data highlighting a novel approach to BioTrak qualification within the SA25 aseptic filling workcell, with 0 viable particle counts seen when conducting extensive baseline and interference testing in a manufacturing environment
  • Find out the impact of the revised EU Annex 1 for rapid microbiological methods implementation
Mike Dingle
Mike Dingle
Senior Product Specialist, Controlled Environments at TSI

Mike Dingle is a Senior Product Specialist at TSI where he provides application support for the BioTrak Real-Time Viable Particle Counter and other TSI products used to test and monitor controlled environments. Prior to joining TSI, Mike worked as a QC Microbiologist in the pharmaceutical and medical device industries for over 20 years where he developed and managed environmental monitoring programs for a wide variety of controlled environments.

Ann Carwell
Ann Carwell
Sales Manager, Contamination Control at TSI

Ann Carwell is an experienced professional in Life Science and contamination control. Currently, she serves as the National Sales Manager, Contamination Control group with TSI, Inc. Ann’s career started in Pharmaceutical Manufacturing and has had held a variety of Sales and Sales Management roles. She has worked with Pharmaceutical, Diagnostic Manufacturing and Semiconductor customers.



Michael J. Miller
Michael J. Miller
President at Microbiology Consultants

Dr. Michael J. Miller is an internationally recognized microbiologist and subject matter expert in pharmaceutical microbiology, contamination control and the validation of rapid microbiological methods. He is the President of Microbiology Consultants, LLC and owner of http://rapidmicromethods.com, an educational website dedicated to the advancement of rapid microbiological methods.

For more than 35 years, he has held numerous R&D, manufacturing, quality, business development and executive leadership roles at Johnson & Johnson, Eli Lilly and Company, Bausch & Lomb, and his consulting company. In his current role, Dr. Miller advises multinational companies in the areas of microbiology, quality and regulatory affairs in support of rapid methods, sterile and non-sterile pharmaceutical manufacturing and contamination control.

Dr. Miller has authored more than 100 technical publications and presentations and currently serves on the editorial and scientific review boards for American Pharmaceutical Review, European Pharmaceutical Review and the PDA Journal. Dr, Miller is the chairperson for the PDA Technical Report #33 revision: and has served as an advisor to the USP Microbiology Expert Committee in the area of rapid sterility testing.

Dr. Miller holds a Ph.D. in Microbiology and Biochemistry from Georgia State University (GSU), a B.A. in Anthropology and Sociology from Hobart College

Noel Long
Noel Long
Senior Sterility Assurance Adviser at Cytiva

Noël Long is a contamination control and sterility assurance professional with in-depth understanding of global regulatory requirements across pharmaceutical, biopharmaceutical, medical device, and healthcare industries. Noël’s experience has focused on aseptic drug product manufacturing and contamination control and reaches across API, cell banking, cell culture, purification, formulation, filtration, aseptic filling, lyophilization, and drug product inspection activities. In her career which includes validation, manufacturing, and quality roles, Noël has held positions of increasing responsibility at Wyeth, GSK, Morphotek, Alexion Pharmaceuticals, GE Healthcare, and Cytiva. Her most recent projects include the airflow visualization studies and biofluorescent particle counter studies for Cytiva’s robotic gloveless filling isolator.